These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 29684567)

  • 1. Human Herpesvirus-6B Reactivation Is a Risk Factor for Grades II to IV Acute Graft-versus-Host Disease after Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
    Phan TL; Carlin K; Ljungman P; Politikos I; Boussiotis V; Boeckh M; Shaffer ML; Zerr DM
    Biol Blood Marrow Transplant; 2018 Nov; 24(11):2324-2336. PubMed ID: 29684567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HHV-6B infection, T-cell reconstitution, and graft-vs-host disease after hematopoietic stem cell transplantation.
    Phan TL; Pritchett JC; Leifer C; Zerr DM; Koelle DM; Di Luca D; Lusso P
    Bone Marrow Transplant; 2018 Dec; 53(12):1508-1517. PubMed ID: 29795424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HHV-6 reactivation and associated sequelae after hematopoietic cell transplantation.
    Zerr DM; Boeckh M; Delaney C; Martin PJ; Xie H; Adler AL; Huang ML; Corey L; Leisenring WM
    Biol Blood Marrow Transplant; 2012 Nov; 18(11):1700-8. PubMed ID: 22641196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations of human herpesvirus 6B and CMV infection with acute GVHD in recipients of allogeneic haematopoietic stem cell transplantation.
    Wang LR; Dong LJ; Zhang MJ; Lu DP
    Bone Marrow Transplant; 2008 Nov; 42(10):673-7. PubMed ID: 18695666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
    Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
    Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Prophylactic Foscarnet on Human Herpesvirus-6 Reactivation and Encephalitis in Cord Blood Transplant Recipients: A Prospective Multicenter Trial with an Historical Control Group.
    Ogata M; Takano K; Moriuchi Y; Kondo T; Ueki T; Nakano N; Mori T; Uoshima N; Nagafuji K; Yamasaki S; Shibasaki Y; Sakai R; Kato K; Choi I; Jo Y; Eto T; Kako S; Oshima K; Fukuda T
    Biol Blood Marrow Transplant; 2018 Jun; 24(6):1264-1273. PubMed ID: 29454651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Human Herpesvirus-6 Reactivation on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation.
    Aoki J; Numata A; Yamamoto E; Fujii E; Tanaka M; Kanamori H
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2017-22. PubMed ID: 26226409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral brincidofovir decreases the incidence of HHV-6B viremia after allogeneic HCT.
    Hill JA; Nichols WG; Marty FM; Papanicolaou GA; Brundage TM; Lanier R; Zerr DM; Boeckh MJ
    Blood; 2020 Apr; 135(17):1447-1451. PubMed ID: 32076716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dynamic time-to-event model for prediction of acute graft-versus-host disease in patients after allogeneic hematopoietic stem cell transplantation.
    Och K; Turki AT; Götz KM; Selzer D; Brossette C; Theobald S; Braun Y; Graf N; Rauch J; Rohm K; Weiler G; Kiefer S; Schwarz U; Eisenberg L; Pfeifer N; Ihle M; Grandjean A; Fix S; Riede C; Rissland J; Smola S; Beelen DW; Kaddu-Mulindwa D; Bittenbring J; Lehr T
    Cancer Med; 2024 Jan; 13(1):e6833. PubMed ID: 38132807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human herpesvirus 6 reactivation in unmanipulated haploidentical hematopoietic stem cell transplantation predicts the occurrence of grade II to IV acute graft-versus-host disease.
    Han TT; Zhang YN; Sun YQ; Kong J; Wang FR; Wang ZD; Cheng YF; Yan CH; Wang Y; Xu LP; Zhang XH; Liu KY; Huang XJ; Zhao XS
    Transpl Infect Dis; 2021 Jun; 23(3):e13544. PubMed ID: 33326670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term prognosis of human herpesvirus 6 reactivation following allogeneic hematopoietic stem cell transplantation.
    Iesato K; Hori T; Yoto Y; Yamamoto M; Inazawa N; Kamo K; Ikeda H; Iyama S; Hatakeyama N; Iguchi A; Sugita J; Kobayashi R; Suzuki N; Tsutsumi H
    Pediatr Int; 2018 Jun; 60(6):547-552. PubMed ID: 29542206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Herpes Virus-6 (HHV-6) Reactivation after Hematopoietic Cell Transplant and Chimeric Antigen Receptor (CAR)- T Cell Therapy: A Shifting Landscape.
    Kampouri E; Handley G; Hill JA
    Viruses; 2024 Mar; 16(4):. PubMed ID: 38675841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis.
    Hill JA; Koo S; Guzman Suarez BB; Ho VT; Cutler C; Koreth J; Armand P; Alyea EP; Baden LR; Antin JH; Soiffer RJ; Marty FM
    Biol Blood Marrow Transplant; 2012 Nov; 18(11):1638-48. PubMed ID: 22564265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of human herpesvirus 6B reactivation on early complications following allogeneic hematopoietic stem cell transplantation.
    Wang LR; Dong LJ; Zhang MJ; Lu DP
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1031-7. PubMed ID: 17067909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivation of human herpesvirus 6 in pediatric allogeneic hematopoietic stem cell transplant recipients.
    Pawlowska AB; Karras NA; Liu H; DiMundo J; Cheng JC; Sun W; Armenian S; Yang D; Palmer JM; Bell A; Tahoun A; Tegtmeier B; Dadwal S; Rosenthal J
    Transpl Infect Dis; 2021 Feb; 23(1):e13453. PubMed ID: 32860467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivation of Human Herpes Virus-6 After Pediatric Stem Cell Transplantation: Risk Factors, Onset, Clinical Symptoms and Association With Severity of Acute Graft-Versus-Host Disease.
    Verhoeven DH; Claas EC; Jol-van der Zijde CM; Thijssen JC; Lankester AC; Bredius RG; Putter H; Kroes AC; Egeler RM; Schilham MW; van Tol MJ
    Pediatr Infect Dis J; 2015 Oct; 34(10):1118-27. PubMed ID: 26132825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human CD134 (OX40) expressed on T cells plays a key role for human herpesvirus 6B replication after allogeneic hematopoietic stem cell transplantation.
    Nagamata S; Nagasaka M; Kawabata A; Kishimoto K; Hasegawa D; Kosaka Y; Mori T; Morioka I; Nishimura N; Iijima K; Yamada H; Kawamoto S; Yakushijin K; Matsuoka H; Mori Y
    J Clin Virol; 2018 May; 102():50-55. PubMed ID: 29494951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diarrhea during the conditioning regimen is correlated with the occurrence of severe acute graft-versus-host disease through systemic release of inflammatory cytokines.
    Liu D; Yan C; Xu L; Wang Y; Han W; Zhang X; Liu K; Huang X
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1567-75. PubMed ID: 20546909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human herpesvirus 6 variant B infection in adult patients after unrelated cord blood transplantation.
    Tomonari A; Takahashi S; Ooi J; Iseki T; Takasugi K; Uchiyama M; Konuma T; Futami M; Ohno N; Uchimaru K; Tojo A; Asano S
    Int J Hematol; 2005 May; 81(4):352-5. PubMed ID: 15914369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritransplant Serum Albumin Decline Predicts Subsequent Severe Acute Graft-versus-Host Disease after Mucotoxic Myeloablative Conditioning.
    Rashidi A; DiPersio JF; Westervelt P; Abboud CN; Schroeder MA; Cashen AF; Pusic I; Romee R
    Biol Blood Marrow Transplant; 2016 Jun; 22(6):1137-1141. PubMed ID: 26988741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.